当前位置： SCI文献检索 > Pulmonary Circulation期刊下所有文献 > Abnormalities in hyperpolarized (129)Xe magnetic resonance imaging and spectroscopy in two patients with pulmonary vascular disease.

Abnormalities in hyperpolarized (129)Xe magnetic resonance imaging and spectroscopy in two patients with pulmonary vascular disease.

Abstract：

:The diagnosis of pulmonary vascular disease (PVD) is usually based on hemodynamic and/or clinical criteria. Noninvasive imaging of the heart and proximal vasculature can also provide useful information. An alternate approach to such criteria in the diagnosis of PVD is to image the vascular abnormalities in the lungs themselves. Hyperpolarized (HP) (129)Xe magnetic resonance imaging (MRI) is a novel technique for assessing abnormalities in ventilation and gas exchange in the lungs. We applied this technique to two patients for whom there was clinical suspicion of PVD. Two patients who had significant hypoxemia and dyspnea with no significant abnormalities on computed tomography imaging or ventilation-perfusion scan and only mild or borderline pulmonary arterial hypertension at catheterization were evaluated. They underwent HP (129)Xe imaging and subsequently had tissue diagnosis obtained from lung pathology. In both patients, HP (129)Xe imaging demonstrated normal ventilation but markedly decreased gas transfer to red blood cells with focal defects on imaging, a pattern distinct from those previously described for idiopathic pulmonary fibrosis or obstructive lung disease. Pathology on both patients later demonstrated severe PVD. These findings suggest that HP (129)Xe MRI may be useful in the diagnosis of PVD and monitoring response to therapy. Further studies are required to determine its sensitivity and specificity in these settings.

journal_name

Pulm Circ

journal_title

Pulmonary circulation

authors

Dahhan T,Kaushik SS,He M,Mammarappallil JG,Tapson VF,McAdams HP,Sporn TA,Driehuys B,Rajagopal S

doi

10.1086/685110

subject

Has Abstract

pub_date

2016-03-01 00:00:00

pages

126-31

issue

1

eissn

2045-8932

issn

2045-8940

pii

PC2013270

journal_volume

6

pub_type

相关文献

Pulmonary Circulation文献大全
  • Occult catheter rupture causing episodic symptoms in a patient treated with epoprostenol.

    abstract：:Infection, thrombosis, and catheter dislodgment are well-recognized potential complications of chronic intravenous prostanoid therapy for pulmonary arterial hypertension. As long-term outcomes of pulmonary hypertension patients improve, novel adverse events are likely to arise. We describe the sudden development of un...

    journal_title：Pulmonary circulation

    pub_type：

    doi：10.1177/2045893217748054

    authors： LeVarge BL,Law AC,Murphy B

    更新日期：2018-01-01 00:00:00

  • Furegrelate, a thromboxane synthase inhibitor, blunts the development of pulmonary arterial hypertension in neonatal piglets.

    abstract：:The development of pulmonary arterial hypertension (PAH) in pediatric patients has been linked to the production of the arachidonic acid metabolite, thromboxane A(2) (TxA(2)). The present study evaluated the therapeutic effect of furegrelate sodium, a thromboxane synthase inhibitor, on the development of PAH in a neon...

    journal_title：Pulmonary circulation

    pub_type： 杂志文章

    doi：10.4103/2045-8932.97605

    authors： Hirenallur-S DK,Detweiler ND,Haworth ST,Leming JT,Gordon JB,Rusch NJ

    更新日期：2012-04-01 00:00:00

  • Non-invasive right ventricular load adaptability indices in patients with scleroderma-associated pulmonary arterial hypertension.

    abstract：:Scleroderma-associated pulmonary arterial hypertension (SSc-PAH) is associated with worse outcome than idiopathic pulmonary arterial hypertension (IPAH), potentially due to worse right ventricular adaptation to load as suggested by pressure-volume loop analysis. The value of non-invasive load-adaptability metrics has ...

    journal_title：Pulmonary circulation

    pub_type： 杂志文章

    doi：10.1177/2045894018788268

    authors： French S,Amsallem M,Ouazani N,Li S,Kudelko K,Zamanian RT,Haddad F,Chung L

    更新日期：2018-07-01 00:00:00

  • Late-onset pulmonary arterial hypertension in repaired D-transposition of great arteries: an uncommon complication.

    abstract：:Late-onset pulmonary arterial hypertension (PAH) is a rare but fatal complication in patients with childhood surgical repair of dextro-transposition of great arteries (D-TGA), especially with the Mustard and Senning procedures. The pathogenic mechanisms of PAH in patients with repaired D-TGA are not well understood an...

    journal_title：Pulmonary circulation

    pub_type：

    doi：10.1177/2045893217699228

    authors： Baskaran J,March KS,Thenappan T

    更新日期：2017-04-01 00:00:00

  • Dosing characteristics of oral treprostinil in real-world clinical practice.

    abstract：:Pharmacokinetic studies with oral treprostinil demonstrate that three times daily (TID) dosing reduces peak-to-trough plasma trepostinil fluctuations compared with twice daily (BID) dosing. TID dosing may allow for faster titration, higher total daily doses, and potentially improve the tolerability of oral trepostinil...

    journal_title：Pulmonary circulation

    pub_type： 杂志文章

    doi：10.1177/2045894018770654

    authors： Balasubramanian VP,Messick CR,Broderick M,Nelsen AC

    更新日期：2018-04-01 00:00:00

  • Reactive oxygen species scavengers improve voltage-gated K(+) channel function in pulmonary arteries of newborn pigs with progressive hypoxia-induced pulmonary hypertension.

    abstract：:Abstract Changes in voltage-gated K(+) (Kv) channel function contribute to the pathogenesis of pulmonary hypertension. Yet the mechanisms underlying Kv channel impairments in the pulmonary circulation remain unclear. We tested the hypothesis that reactive oxygen species (ROSs) contribute to the Kv channel dysfunction ...

    journal_title：Pulmonary circulation

    pub_type： 杂志文章

    doi：10.1086/674307

    authors： Fike CD,Aschner JL,Kaplowitz MR,Zhang Y,Madden JA

    更新日期：2013-09-01 00:00:00

  • Mechanical forces stimulate endothelial microparticle generation via caspase-dependent apoptosis-independent mechanism.

    abstract：:Microparticle release by vascular endothelium has been implicated in various cardiovascular pathologies. Ventilator-induced lung injury (VILI) is a life-threatening complication of mechanical ventilation at high tidal volumes associated with excessive mechanical stretch of pulmonary vascular endothelial cells. However...

    journal_title：Pulmonary circulation

    pub_type： 杂志文章

    doi：10.4103/2045-8932.109921

    authors： Vion AC,Birukova AA,Boulanger CM,Birukov KG

    更新日期：2013-01-01 00:00:00

  • Compensated right ventricular function of the onset of pulmonary hypertension in a rat model depends on chamber remodeling and contractile augmentation.

    abstract：:Right-ventricular function is a good indicator of pulmonary arterial hypertension (PAH) prognosis; however, how the right ventricle (RV) adapts to the pressure overload is not well understood. Here, we aimed at characterizing the time course of RV early remodeling and discriminate the contribution of ventricular geome...

    journal_title：Pulmonary circulation

    pub_type： 杂志文章

    doi：10.1177/2045894018800439

    authors： Vélez-Rendón D,Zhang X,Gerringer J,Valdez-Jasso D

    更新日期：2018-10-01 00:00:00

  • Transforming growth factor-β inhibition and endothelin receptor blockade in rats with monocrotaline-induced pulmonary hypertension.

    abstract：:Transforming growth factor-β (TGF-β) inhibition is an investigational therapy for pulmonary arterial hypertension with promising results in experimental studies. The present work compared this approach with endothelin-receptor blockade and evaluated the effects of combined administration. Pulmonary arterial hypertensi...

    journal_title：Pulmonary circulation

    pub_type： 杂志文章

    doi：10.4103/2045-8932.105034

    authors： Megalou AJ,Glava C,Vilaeti AD,Oikonomidis DL,Baltogiannis GG,Papalois A,Vlahos AP,Kolettis TM

    更新日期：2012-10-01 00:00:00

  • Survey of practices in relation to chronic pulmonary hypertension in neonates in the Canadian Neonatal Network and the National Institute of Child Health and Human Development Neonatal Research Network.

    abstract：:Current knowledge gaps pertaining to diagnosis and management of neonatal chronic pulmonary hypertension (cPH) may result in significant variability in clinical practice. The objective of the study is to understand cPH management practices in neonatal intensive care units affiliated with the Canadian Neonatal Network ...

    journal_title：Pulmonary circulation

    pub_type： 杂志文章

    doi：10.1177/2045894020937126

    authors： Baczynski M,Bell EF,Finan E,McNamara PJ,Jain A

    更新日期：2020-07-16 00:00:00

  • Bioavailability, pharmacokinetics, and safety of riociguat given as an oral suspension or crushed tablet with and without food.

    abstract：:Riociguat is approved for the treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. Some patients have difficulty swallowing tablets; therefore, 2 randomized, nonblinded, crossover studies compared the relative bioavailability of riociguat oral suspensions and immediate-releas...

    journal_title：Pulmonary circulation

    pub_type： 杂志文章

    doi：10.1086/685020

    authors： Saleh S,Frey R,Becker C,Unger S,Wensing G,Mück W

    更新日期：2016-03-01 00:00:00

  • Idiopathic hypereosinophilic syndrome with pulmonary hypertension.

    abstract：:Hypereosinophilic syndrome is a myeloproliferative disorder characterized by persistent eosinophilia with involvement of multiple organs. The occurrence of severe pulmonary hypertension (PH) in the setting of hypereosinophilic syndrome is very uncommon. A 43-year-old man with documented idiopathic hypereosinophlic syn...

    journal_title：Pulmonary circulation

    pub_type：

    doi：10.1177/2045894018793999

    authors： Zhang L,Peng X,Adhikari BK,Li B,Liu Q,Mikeladze J,Zhang W

    更新日期：2019-01-01 00:00:00

  • Advancing clinical trial design in pulmonary hypertension.

    abstract：:In pulmonary hypertension, as in many other diseases, there is a need for a smarter approach to evaluating new treatments. The traditional randomized controlled trial has served medical science well, but constrains the development of treatments for rare diseases. A workshop was established to consider alternative clin...

    journal_title：Pulmonary circulation

    pub_type： 杂志文章

    doi：10.4103/2045-8932.109933

    authors： Grieve AP,Chow SC,Curram J,Dawe S,Harnisch LO,Henig NR,Hung HM,Ivy DD,Kawut SM,Rahbar MH,Xiao S,Wilkins MR

    更新日期：2013-01-01 00:00:00

  • The anticoagulant effects of warfarin and the bleeding risk associated with its use in patients with chronic thromboembolic pulmonary hypertension at a specialist center in Japan: a retrospective cohort study.

    abstract：:Patients with chronic thromboembolic pulmonary hypertension (CTEPH) require lifelong anticoagulation therapy. However, the bleeding risk and recurrence of venous thromboembolism (VTE) in CTEPH patients who are administered warfarin have not been adequately evaluated. The purpose of this study was to evaluate the risk ...

    journal_title：Pulmonary circulation

    pub_type： 杂志文章

    doi：10.1177/2045893217717258

    authors： Jujo-Sanada T,Tanabe N,Sakao S,Sugiura T,Sekine A,Nishimura R,Suda R,Naito A,Miwa H,Yamamoto K,Sasaki A,Matsumura A,Ema R,Kasai H,Kato F,Tatsumi K

    更新日期：2017-07-01 00:00:00

  • Obesity-related pulmonary arterial hypertension in rats correlates with increased circulating inflammatory cytokines and lipids and with oxidant damage in the arterial wall but not with hypoxia.

    abstract：:Obesity is causally linked to a number of comorbidities, including cardiovascular disease, diabetes, renal dysfunction, and cancer. Obesity has also been linked to pulmonary disorders, including pulmonary arterial hypertension (PAH). It was long believed that obesity-related PAH was the result of hypoventilation and h...

    journal_title：Pulmonary circulation

    pub_type： 杂志文章

    doi：10.1086/678510

    authors： Irwin DC,Garat CV,Crossno JT Jr,MacLean PS,Sullivan TM,Erickson PF,Jackman MR,Harral JW,Reusch JE,Klemm DJ

    更新日期：2014-12-01 00:00:00

  • Novel composite clinical endpoints and risk scores used in clinical trials in pulmonary arterial hypertension.

    abstract：:This manuscript on endpoints incorporates the broad experience of members of Pulmonary Vascular Research Institute's Innovative Drug Development Initiative as an open debate platform for academia, the pharmaceutical industry and regulatory experts surrounding the future design of clinical trials in pulmonary hypertens...

    journal_title：Pulmonary circulation

    pub_type： 杂志文章

    doi：10.1177/2045894020962960

    authors： Sitbon O,Nikkho S,Benza R,Cq Deng C,W Farber H,Gomberg-Maitland M,Hassoun P,Meier C,Pepke-Zaba J,Prasad K,Seeger W,Corris PA

    更新日期：2020-11-18 00:00:00

  • Pulmonary capillary hemangiomatosis: the role of invasive cardiopulmonary exercise testing.

    abstract：:Pulmonary capillary hemangiomatosis (PCH) is a rare form of pulmonary arterial hypertension (PAH) characterized by pulmonary capillary proliferation and pseudoinvasion of collagenous septal structures. PCH is often accompanied by veno-occlusive changes and pulmonary hypertensive arterial remodeling. The clinical and p...

    journal_title：Pulmonary circulation

    pub_type：

    doi：10.1086/682227

    authors： DuBrock HM,Kradin RL,Rodriguez-Lopez JM,Channick RN

    更新日期：2015-09-01 00:00:00

  • Pulmonary vasospasm in systemic sclerosis: noninvasive techniques for detection.

    abstract：:In a subgroup of patients with systemic sclerosis (SSc), vasospasm affecting the pulmonary circulation may contribute to worsening respiratory symptoms, including dyspnea. Noninvasive assessment of pulmonary blood flow (PBF), utilizing inert-gas rebreathing (IGR) and dual-energy computed-tomography pulmonary angiograp...

    journal_title：Pulmonary circulation

    pub_type： 杂志文章

    doi：10.1086/682221

    authors： Keir GJ,Nair A,Giannarou S,Yang GZ,Oldershaw P,Wort SJ,MacDonald P,Hansell DM,Wells AU

    更新日期：2015-09-01 00:00:00

  • Serum soluble suppression of tumorigenicity-2 level associates with severity of pulmonary hypertension associated with uncorrected atrial septal defect.

    abstract：:Uncorrected atrial septal defect undergoes right ventricle chronic volume overload which may lead to pulmonary hypertension and Eisenmenger Syndrome. The soluble suppression of tumorigenicity-2 is a left ventricle strain biomarker; however, its role in right ventricle strain is unclear. This study aimed to investigate...

    journal_title：Pulmonary circulation

    pub_type： 杂志文章

    doi：10.1177/2045894020915832

    authors： Pratama RS,Hartopo AB,Anggrahini DW,Dewanto VC,Dinarti LK

    更新日期：2020-05-26 00:00:00

  • Impact of four times daily dosing of oral treprostinil on tolerability and daily dose achieved in pulmonary hypertension.

    abstract：:Oral treprostinil (TRE) is a prostacylin that is approved for the treatment of patients with pulmonary arterial hypertension (PAH). Dosing is approved for two or three times daily (t.i.d.); however, adverse effects, including gastrointestinal-related symptoms, may limit the ability to reach optimal doses. We report ou...

    journal_title：Pulmonary circulation

    pub_type：

    doi：10.1177/2045893217744512

    authors： Coons JC,Bunner C,Ishizawar DC,Risbano MG,Rivera-Lebron B,Mathier MA,Chan SY,Simon MA

    更新日期：2018-01-01 00:00:00

  • Impact of histologic chorioamnionitis on pulmonary hypertension and respiratory outcomes in preterm infants.

    abstract：:We aimed to evaluate the association between the presence of histologic chorioamnionitis (HC) and development of pulmonary hypertension (PH) during neonatal intensive care unit (NICU) stay. Data of preterm infants born at 32 weeks of gestation or less were reviewed. The development of PH and other respiratory outcomes...

    journal_title：Pulmonary circulation

    pub_type： 杂志文章

    doi：10.1177/2045894018760166

    authors： Yum SK,Kim MS,Kwun Y,Moon CJ,Youn YA,Sung IK

    更新日期：2018-04-01 00:00:00

  • Significant intrapulmonary Schistosoma egg antigens are not present in schistosomiasis-associated pulmonary hypertension.

    abstract：:Schistosomiasis-associated pulmonary arterial hypertension (PAH) is one of the most common causes of pulmonary hypertension worldwide. A potential contributing mechanism to the pathogenesis of this disease is a localized immune reaction to retained and persistent parasite-derived antigens. We sought to identify Schist...

    journal_title：Pulmonary circulation

    pub_type： 杂志文章

    doi：10.4103/2045-8932.93544

    authors： Graham BB,Chabon J,Bandeira A,Espinheira L,Butrous G,Tuder RM

    更新日期：2011-10-01 00:00:00

  • Trends in pediatric pulmonary hypertension-related hospitalizations in the United States from 2000-2009.

    abstract：:There are few data on the epidemiology of pulmonary hypertension (PH)-related hospitalizations in children in the United States. Our aim was to determine hospital mortality, length of hospitalization, and hospital charges pertaining to PH-related hospitalizations and also the effects of codiagnoses and comorbidities. ...

    journal_title：Pulmonary circulation

    pub_type： 杂志文章

    doi：10.1086/681226

    authors： Frank DB,Crystal MA,Morales DL,Gerald K,Hanna BD,Mallory GB Jr,Rossano JW

    更新日期：2015-06-01 00:00:00

  • Understanding longitudinal biventricular structural and functional changes in a pulmonary hypertension Sugen-hypoxia rat model by cardiac magnetic resonance imaging.

    abstract：:Cardiac magnetic resonance-derived ventricular variables are predictive of mortality in pulmonary arterial hypertension. Rodent models which emphasize ventricular function, allowing serial monitoring, are needed to identify pathophysiological features and novel therapies for pulmonary arterial hypertension. We investi...

    journal_title：Pulmonary circulation

    pub_type： 杂志文章

    doi：10.1177/2045894019897513

    authors： Jayasekera G,Wilson KS,Buist H,Woodward R,Uckan A,Hughes C,Nilsen M,Church AC,Johnson MK,Gallagher L,Mullin J,MacLean MR,Holmes WM,Peacock AJ,Welsh DJ

    更新日期：2020-02-10 00:00:00

  • Incidence and risk factors of chronic thromboembolic pulmonary hypertension following venous thromboembolism, a population-based cohort study in England.

    abstract：:Chronic thromboembolic pulmonary hypertension (CTEPH) is a complication of unresolved organised pulmonary emboli/thrombi obstructing the major pulmonary arteries. The aim of this study was to estimate the incidence and risk factors of CTEPH in a cohort with first venous thromboembolism (VTE). This was a population-bas...

    journal_title：Pulmonary circulation

    pub_type： 杂志文章

    doi：10.1177/2045894018791358

    authors： Martinez C,Wallenhorst C,Teal S,Cohen AT,Peacock AJ

    更新日期：2018-07-01 00:00:00

  • Impact of diabetes on survival and right ventricular compensation in pulmonary arterial hypertension.

    abstract：:Insulin resistance is highly prevalent in pulmonary arterial hypertension (PAH) patients. However, the long-term impact of diabetes mellitus (DM) on survival in PAH is unclear. Insulin resistance and DM are associated with left ventricular steatosis and dysfunction, but whether the right ventricle (RV) might be affect...

    journal_title：Pulmonary circulation

    pub_type： 杂志文章

    doi：10.1086/675994

    authors： Benson L,Brittain EL,Pugh ME,Austin ED,Fox K,Wheeler L,Robbins IM,Hemnes AR

    更新日期：2014-06-01 00:00:00

  • The unique heart sound signature of children with pulmonary artery hypertension.

    abstract：:We hypothesized that vibrations created by the pulmonary circulation would create sound like the vocal cords during speech and that subjects with pulmonary artery hypertension (PAH) might have a unique sound signature. We recorded heart sounds at the cardiac apex and the second left intercostal space (2LICS), using a ...

    journal_title：Pulmonary circulation

    pub_type： 杂志文章

    doi：10.1086/683694

    authors： Elgendi M,Bobhate P,Jain S,Guo L,Kumar S,Rutledge J,Coe Y,Zemp R,Schuurmans D,Adatia I

    更新日期：2015-12-01 00:00:00

  • Deregulated angiogenesis in chronic lung diseases: a possible role for lung mesenchymal progenitor cells (2017 Grover Conference Series).

    abstract：:Chronic lung disease (CLD), including pulmonary fibrosis (PF) and chronic obstructive pulmonary disease (COPD), is the fourth leading cause of mortality worldwide. Both are debilitating pathologies that impede overall tissue function. A common co-morbidity in CLD is vasculopathy, characterized by deregulated angiogene...

    journal_title：Pulmonary circulation

    pub_type： 杂志文章

    doi：10.1177/2045893217739807

    authors： Kropski JA,Richmond BW,Gaskill CF,Foronjy RF,Majka SM

    更新日期：2018-01-01 00:00:00

  • Log-transformation improves the prognostic value of serial NT-proBNP levels in apparently stable pulmonary arterial hypertension.

    abstract：:N-terminal pro B-type natriuretic peptide (NT-proBNP) is a product of cleavage of the cardiac prohormone pro B-type natriuretic peptide into its active form. It has proven to be a useful biomarker in left heart failure. However, studies examining the utility of serial measurements of NT-proBNP in pulmonary arterial hy...

    journal_title：Pulmonary circulation

    pub_type： 杂志文章

    doi：10.4103/2045-8932.83450

    authors： Soon E,Doughty NJ,Treacy CM,Ross RM,Toshner M,Upton PD,Sheares K,Morrell NW,Pepke-Zaba J

    更新日期：2011-04-01 00:00:00

  • 'Tired, afraid, breathless … .' An international survey of the exercise experience for people living with pulmonary hypertension.

    abstract：:Patients with pulmonary hypertension are more sedentary than the general population, but attitudes and experiences that may influence their exercise behaviour remain poorly understood. This study identified patterns of behaviour, attitudes towards exercise, barriers and enablers of exercise for people living with pulm...

    journal_title：Pulmonary circulation

    pub_type： 杂志文章

    doi：10.1177/2045894020968023

    authors： Chia KSW,Brown K,Kotlyar E,Wong PKK,Faux SG,Shiner CT

    更新日期：2020-11-16 00:00:00